During hypoglycaemia, insulin secretion is reduced and glucagon secretion is not inhibited
Key strategies include: Medication Adjustment : For patients at high risk of hypoglycemia, healthcare providers may consider adjusting the dose of semaglutide or other concomitant diabetes medications
Staying hydrated and consuming adequate protein helps minimize fatigue while maximizing fat loss
Enhanced treatment tolerance: Research indicates IV vitamin C may help people tolerate chemotherapy better, potentially reducing fatigue, nausea, and other side effects while maintaining treatment effectiveness
Morning injection protocol: Wake, inject AOD-9604 on a completely empty stomach, wait 20-30 minutes, then eat breakfast
Blood glucose monitoring is recommended for anyone at risk of hypoglycaemia